IL17A and type 1 diabetes mellitus: Consistently, in a previous publication using a type 1 diabetes disease model involving adoptive transfer of diabetogenic T cells into NOD/SCID mice, the co-transfer of normal splenic γδ T cells capable of producing IL-17 was found to reduce disease incidence [6].